RankAlpha logo
Back to Rankings

FULC

Fulcrum TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
FULC vs peer average
36/100
FULC vs. peer average (F vs. D)
Grade spread
B 1 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

RNAC is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $240.34M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRNACCartesian Therapeutics
FULC
Fulcrum Therapeutics
RNAC
Cartesian Therapeutics
Grade
F
B
Momentum
2
85
Value
57
41
Sentiment
-
61
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs RNAC

FULC / RNAC
Grade Position
Below peers
FULC vs. peer average (F vs. D)
36/100
Momentum
2
RNAC
Value
57
FULC
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs FULC
1
RNAC
Cartesian Therapeutics Inc Common
B
80/100
-3
2
PRQR
ProQR Therapeutics NV Common
F
20/100
Even
3
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
D
40/100
-1
4
TRDA
Entrada Therapeutics Inc Common
F
20/100
Even
5
ZSQR
Z Squared Inc Common
C
60/100
-2
RNAC is the first peer returned for this comparison set.